XJ02862-S2
Product Specifications
UNSPSC Description
XJ02862-S2 shows potent FXR agonistic activity. XJ02862-S2 is a promising lead compound for the research of NAFLD[1].
Target Antigen
FXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/xj02862-s2.html
Solubility
10 mM in DMSO
Smiles
C[C@H]1C[C@H](C2=CC=CC=C2N1C([C@@H](N3C(C4CCCCC4C3=O)=O)C)=O)NC5=CC=CC=C5
Molecular Weight
445.55
References & Citations
[1]Tong Qin, et al. Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease. Eur J Med Chem. 2023 Apr 5;252:115307.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-149971/XJ02862-S2-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-149971/
Clinical Information
No Development Reported
CAS Number
3023355-55-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items